Company Filing History:
2 out of 3 
1 out of 417 
1 out of 329 Years Active: 2005-2007
Title: Tohru Sugimoto: Innovator in Peptide Leukotriene Receptor Research
Introduction
Tohru Sugimoto is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of biochemistry, particularly in the area of peptide leukotriene receptors. With a total of 2 patents, his work has paved the way for advancements in drug development targeting these receptors.
Latest Patents
Sugimoto's latest patents focus on a cDNA encoding a novel leukotriene receptor. This innovative receptor has been isolated, allowing for binding experiments using leukotriene C (LTC). By screening for compounds that modulate leukotriene receptor activity based on these binding experiments, the development of drugs targeting the leukotriene receptor becomes possible. This research holds promise for therapeutic applications in various medical conditions.
Career Highlights
Throughout his career, Sugimoto has worked with notable organizations such as Helix Research Institute and Astellas Pharma GmbH. His experience in these companies has contributed to his expertise in receptor research and drug development.
Collaborations
Sugimoto has collaborated with esteemed colleagues, including Jun Takasaki and Masazumi Kamohara. These partnerships have further enhanced his research and innovation in the field.
Conclusion
Tohru Sugimoto's work in peptide leukotriene receptor research exemplifies the impact of innovative thinking in biochemistry. His contributions are vital for the future of drug development targeting these important receptors.